Jialing Deng
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production.
Journal: Frontiers in pharmacology
Published: July 23, 2025
Discovery and Optimization of Potent PROTAC Degraders of Phosphoinositide 3-Kinase with Significant in Vivo Anticancer Efficacy.
Journal: Journal of medicinal chemistry
Published: June 16, 2025
Design, Synthesis, and Biological Evaluation of Novel Fms-Like Tyrosine Kinase 3/VEGFR2/Histone Deacetylase Inhibitors for the Treatment of Acute Myeloid Leukemia.
Journal: Journal of medicinal chemistry
Published: February 19, 2025
Chemistry and biology of natural stilbenes: an update.
Journal: Natural product reports
Published: December 23, 2024
Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: February 20, 2024
LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.
Journal: Lipids in health and disease
Published: February 04, 2024
Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis.
Journal: Journal of medicinal chemistry
Published: October 16, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026